Deprecated!
This application is deprecated. Please use the latest version of the tool here.
Please cite:
I. S. Vlachos, M. D. Paraskevopoulou, D. Karagkouni, G. Georgakilas, T. Vergoulis, I. Kanellos, I-L. Anastasopoulos, S. Maniou, K. Karathanou, D. Kalfakakou, A. Fevgas, T. Dalamagas and A. G. Hatzigeorgiou. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucl. Acids Res. (2014)
Data Download:
DIANA-TarBase v7 is available for scientific non-profit and non-commercial use! Download TarBase v7 by following this link
|
||||||||
Related Pathways
Publication year
Prediction score
Filters
Selected:
Species: -
Regulation: -
Validation: -
Validated: -
Sources: -
Methods: -
Species: -
Regulation: -
Validation: -
Validated: -
Sources: -
Methods: -
Remove all 

Species

Method Type

Method

Regulation type

Validation type

Validated as

Source

Publication year
Prediction score
Loading...![]() |
| Wait until the result set is completed... |
Gene name
miRNA name
Methods
Pred.Score
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:49053682-49053704 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:49050265-49050288 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:244055430-244055454 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:244055430-244055454 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr1:244055430-244055454 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:244055430-244055454 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:205614420-205614439 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:24718871-24718883 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr6:24719535-24719547 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 3 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:69269555-69269581 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr18:57482436-57482449 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:3535451-3535467 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:62713153-62713176 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:149490592-149490615 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:128824987-128825014 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:73258462-73258484 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:138506505-138506523 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:56710030-56710053 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:139509323-139509340 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:10378026-10378053 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:10378026-10378053 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:113015029-113015054 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr20:59030394-59030415 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:76734545-76734566 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:138339127-138339145 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:49033530-49033557 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr12:49032921-49032934 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:45711540-45711564 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:85544796-85544815 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:105307802-105307823 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:65171097-65171120 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:94853955-94853980 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:100682075-100682092 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:100681180-100681203 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:100682078-100682092 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:100683355-100683380 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:100682087-100682114 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:100682075-100682092 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:100683192-100683219 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:100684272-100684295 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:56938760-56938779 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:1257591-1257610 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:1257591-1257610 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:1257591-1257610 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
EMC10 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:50483284-50483308 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
BAHCC1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:81443173-81443194 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TBC1D2 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:98220854-98220875 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
UBC (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:124911825-124911851 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr12:124911825-124911851 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr12:124913649-124913675 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MAP3K4 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:161048913-161048933 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TNPO2 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:12720942-12720964 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
EEF1D (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:143596651-143596673 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
FDPS (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:155320458-155320485 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:155320458-155320485 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PSMB2 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:35631318-35631339 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
LIG1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:48140029-48140050 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CNOT3 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:54153732-54153760 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
VRK2 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:58135172-58135195 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NME4 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:397928-397941 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SMEK2 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:55564390-55564410 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PRRC2B (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:131497110-131497127 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr9:131497110-131497127 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:131497378-131497403 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TSC2 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:2075822-2075846 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF554 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:2820103-2820126 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
FAM133B (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:92565878-92565904 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
POLQ (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:121490373-121490396 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
FUS (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:31183955-31183976 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:31183966-31183990 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:31183966-31183990 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:31184329-31184347 (UNKNOWN)
AGO2 PAR-CLIP, 2 replicates available. T1 RNase-treated samples

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:31184329-31184347 (UNKNOWN)
LCL-BACD3 lymphoblastoid cells infected by EBV B95-8 BACmid. LCL-BAC-D1 cells were generated from the same donor as LCL-BAC and are mutationally inactivated for miR-BHRF1-3 expression. antibody: Anti-Ago2 (clone 9E8).

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SYNCRIP (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:85612261-85612284 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PHF10 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:169707283-169707301 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NKD2 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:1034805-1034826 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CPVL (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:29071826-29071847 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PTPRJ (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:48169534-48169556 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PDE4DIP (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:149016433-149016455 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CEP41 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:130400184-130400211 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PSMD6 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:64018658-64018684 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
INPPL1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:72229029-72229056 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TRIM26 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:30199134-30199156 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MED22 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:133343118-133343142 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:133343118-133343142 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HIRA (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr22:19383669-19383690 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
GPSM1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:136355581-136355603 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr9:136355581-136355603 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:136355581-136355603 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HUWE1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:53546764-53546789 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
UBR4 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:19201784-19201804 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:19155501-19155521 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:19117361-19117382 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
KDM4C (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:6990482-6990508 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
UBE2J2 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:1255447-1255455 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ASB15 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:123604055-123604083 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ST14 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:130209537-130209559 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PAFAH1B2 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:117152474-117152493 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:117152474-117152493 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr11:117152474-117152493 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:117152474-117152493 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:117152474-117152493 (UNKNOWN)
AGO2 PAR-CLIP, 2 replicates available. MNase-treated samples

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr11:117152474-117152493 (UNKNOWN)
AGO2 PAR-CLIP, 2 replicates available. T1 RNase-treated samples

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:117152474-117152493 (UNKNOWN)
HEK293 stably expressing Flag/HA–AGO1 and Flag/HA–AGO2. Immunoprecipitation was carried out with proteinGmagnetic beads (Invitrogen) coupled to anti-Flag antibody (Sigma) and to anti-AGO2 antibody

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ADARB1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr21:45223951-45223970 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
POLG (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr15:89320795-89320822 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
C21orf2 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr21:44329054-44329075 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CNTNAP5 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:124747284-124747312 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
H3F3B (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:75778404-75778428 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:75778404-75778428 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZBTB7A (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:4055017-4055041 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CEBPD (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:47738434-47738454 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
KDM1A (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:23081540-23081561 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
UBTF (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:44211129-44211151 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
C16orf72 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:9103781-9103799 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
OR10S1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:123976733-123976752 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
DNMT3A (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:25230590-25230610 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NOLC1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:102159229-102159250 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:102159251-102159266 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr10:102159238-102159256 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:102159217-102159242 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:102159238-102159256 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CMTM4 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:66614950-66614977 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:66614950-66614977 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
RESP18 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:219329701-219329720 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
AES (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:3054038-3054044 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:3054038-3054044 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
RPS11 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:49499597-49499621 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TRIM65 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:75892815-75892834 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
RBM4B (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:132023343-132023368 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PABPC1L (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr20:44932212-44932234 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PKN1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:14443528-14443550 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
LIPA (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:89215965-89215987 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SURF6 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:133331240-133331261 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PTOV1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:49858048-49858070 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
AMOT (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:112777348-112777369 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
P4HB (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:81859253-81859280 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
BTBD3 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr20:11918387-11918403 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TTC33 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:40728431-40728458 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:40728431-40728458 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr5:40728431-40728458 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:40728431-40728458 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr5:40728431-40728458 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HBS1L (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:134962651-134962673 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
GPAA1 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:144084181-144084204 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PSMB8 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:32840832-32840849 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ST6GALNAC5 (hsa) 

hsa-miR-93-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:76868582-76868604 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0

